The Prognostic Value of MDM2, MDM4 (MDMX), and p53 in Early Stage Breast Cancer Treated with Breast Conserving Surgery and Radiotherapy

被引：0
|
作者：
Neboori, H. [1 ,2 ]
Wu, H. [1 ]
Schiff, D. [1 ]
Goyal, S. [1 ]
Moran, M. [3 ]
Yang, J.
Hirshfield, K. M. [1 ]
Haffty, B. G. [1 ]
机构：
[1] UMDNJ, New Brunswick, NJ USA
[2] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA
[3] Yale Univ, New Haven, CT USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2011年 / 81卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2011.06.126
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：S62 / S63
页数：2
相关论文
共 50 条
  • [1] Associations of MDM2 and MDM4 Polymorphisms with Early-Stage Breast Cancer
    Bartnykaite, Agne
    Savukaityte, Aiste
    Ugenskiene, Rasa
    Dauksaite, Monika
    Korobeinikova, Erika
    Gudaitiene, Jurgita
    Juozaityte, Elona
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (04) : 1 - 11
  • [2] The expression of MDM2, MDM4, p53 and p21 in myeloid neoplasms and the effect of MDM2/MDM4 dual inhibitor
    Eskandari, Mohammad
    Shi, Yang
    Liu, John
    Albanese, Joseph
    Goel, Swati
    Verma, Amit
    Wang, Yanhua
    LEUKEMIA & LYMPHOMA, 2021, 62 (01) : 167 - 175
  • [3] Mdm2 Splice isoforms regulate the p53/Mdm2/Mdm4 regulatory circuit via RING domain-mediated ubiquitination of p53 and Mdm4
    Fan, Chuandong
    Wang, Xinjiang
    CELL CYCLE, 2017, 16 (07) : 660 - 664
  • [4] The role of MDM2 and MDM4 in breast cancer development and prevention
    Haupt, Sue
    Vijayakumaran, Reshma
    Miranda, Panimaya Jeffreena
    Burgess, Andrew
    Lim, Elgene
    Haupt, Ygal
    JOURNAL OF MOLECULAR CELL BIOLOGY, 2017, 9 (01) : 53 - 61
  • [5] MDM2, MDMX and p53 in oncogenesis and cancer therapy
    Mark Wade
    Yao-Cheng Li
    Geoffrey M. Wahl
    Nature Reviews Cancer, 2013, 13 : 83 - 96
  • [6] Selective and dual action p53/mdm2/mdm4 antagonists
    Wang, Kan
    Doemling, Alexander
    CANCER RESEARCH, 2009, 69
  • [7] MDM2, MDMX and p53 in oncogenesis and cancer therapy
    Wade, Mark
    Li, Yao-Cheng
    Wahl, Geoffrey M.
    NATURE REVIEWS CANCER, 2013, 13 (02) : 83 - 96
  • [8] MDM2 and MDM4: p53 regulators as targets in anticancer therapy
    Toledo, Franck
    Wahl, Geoffrey M.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2007, 39 (7-8): : 1476 - 1482
  • [9] Mdm2 and Mdm4 loss regulates distinct p53 activities
    Barboza, Juan A.
    Iwakuma, Tomoo
    Terzian, Tamara
    El-Naggar, Adel K.
    Lozano, Guillermina
    MOLECULAR CANCER RESEARCH, 2008, 6 (06) : 947 - 954
  • [10] Heterodimerization of Mdm2 and Mdm4 is critical for regulating p53 activity during embryogenesis but dispensable for p53 and Mdm2 stability
    Pant, Vinod
    Xiong, Shunbin
    Iwakuma, Tomoo
    Quintas-Cardama, Alfonso
    Lozano, Guillermina
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (29) : 11995 - 12000
12345